Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 24% ± 6% | |
| microglial cell | 7 studies | 22% ± 7% | |
| astrocyte | 7 studies | 28% ± 11% | |
| oligodendrocyte precursor cell | 7 studies | 32% ± 14% | |
| epithelial cell | 6 studies | 27% ± 8% | |
| adipocyte | 6 studies | 20% ± 5% | |
| oligodendrocyte | 6 studies | 25% ± 7% | |
| cardiac muscle cell | 5 studies | 29% ± 5% | |
| fibroblast | 5 studies | 22% ± 5% | |
| goblet cell | 5 studies | 23% ± 8% | |
| macrophage | 5 studies | 24% ± 4% | |
| GABAergic neuron | 4 studies | 33% ± 11% | |
| glutamatergic neuron | 4 studies | 40% ± 14% | |
| endothelial cell of lymphatic vessel | 4 studies | 21% ± 3% | |
| retinal rod cell | 3 studies | 17% ± 2% | |
| pericyte | 3 studies | 20% ± 4% | |
| transit amplifying cell | 3 studies | 35% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2069.77 | 1445 / 1445 | 100% | 21.36 | 183 / 183 |
| prostate | 100% | 2418.34 | 245 / 245 | 100% | 27.04 | 502 / 502 |
| lung | 100% | 1968.87 | 577 / 578 | 100% | 16.66 | 1154 / 1155 |
| breast | 100% | 2243.17 | 459 / 459 | 100% | 17.66 | 1115 / 1118 |
| uterus | 100% | 2329.86 | 170 / 170 | 100% | 13.28 | 457 / 459 |
| thymus | 100% | 2173.02 | 653 / 653 | 99% | 16.07 | 601 / 605 |
| intestine | 100% | 2601.24 | 966 / 966 | 99% | 20.66 | 523 / 527 |
| bladder | 100% | 2047.52 | 21 / 21 | 99% | 16.04 | 499 / 504 |
| stomach | 100% | 1716.16 | 359 / 359 | 99% | 20.16 | 283 / 286 |
| ovary | 100% | 2196.96 | 180 / 180 | 99% | 9.06 | 424 / 430 |
| adrenal gland | 100% | 1944.43 | 258 / 258 | 98% | 11.38 | 225 / 230 |
| kidney | 100% | 1340.64 | 89 / 89 | 98% | 12.74 | 880 / 901 |
| skin | 100% | 2810.85 | 1809 / 1809 | 96% | 16.40 | 455 / 472 |
| brain | 99% | 1032.04 | 2612 / 2642 | 97% | 14.67 | 687 / 705 |
| pancreas | 95% | 762.85 | 313 / 328 | 97% | 13.73 | 172 / 178 |
| liver | 99% | 777.88 | 224 / 226 | 83% | 6.62 | 335 / 406 |
| adipose | 100% | 2124.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1780.46 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2319.32 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 14.88 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.25 | 1 / 1 |
| heart | 99% | 1668.08 | 854 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 920.67 | 795 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 9.12 | 28 / 29 |
| eye | 0% | 0 | 0 / 0 | 86% | 8.41 | 69 / 80 |
| peripheral blood | 67% | 826.10 | 620 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_2000058 | Biological process | regulation of ubiquitin-dependent protein catabolic process |
| GO_0031965 | Cellular component | nuclear membrane |
| GO_0030133 | Cellular component | transport vesicle |
| GO_0017080 | Molecular function | sodium channel regulator activity |
| Gene name | TMEM168 |
| Protein name | Transmembrane protein 168 |
| Synonyms | |
| Description | FUNCTION: Plays a key role in maintaining the cardiac electrical stability by modulating cell surface expression of SCN5A . May play a role in the modulation of anxiety behavior by regulating GABAergic neuronal system in the nucleus accumbens (By similarity). . |
| Accessions | H7C268 ENST00000447395.5 [Q9H0V1-2] ENST00000418785.5 Q9H0V1 ENST00000454074.5 [Q9H0V1-1] C9IZT1 ENST00000441474.1 ENST00000312814.11 [Q9H0V1-1] ENST00000449743.1 C9JVE9 |